NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and E6011 Concluded

  • Written by ACN Newswire

image

TOKYO, Oct 6, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global Health and Medicine, Nagasaki University, and Yokohama City University) in Japan concerning the "Development of Therapeutics to Prevent the...

Read more: Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and...